Impact of Pre-Treatment NLR and Other Hematologic Biomarkers on the Outcomes of Early-Stage Non-Small-Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy

Impact of Pre-Treatment NLR and Other Hematologic Biomarkers on the Outcomes of Early-Stage Non-Small-Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy

Introduction: We evaluated the association of pre-treatment immunologic biomarkers on the outcomes of early-stage non-small-cell lung cancer (NSCLC) patients treated with stereotactic body radiation therapy (SBRT). Materials and methods: In this retrospective study, all newly diagnosed early-stage N...

Full description

Bibliographic Details
Main Authors: Marina Aduquaye, Sheen Dube, Bashir Bashir, Amitava Chowdhury, Naseer Ahmed, Ahmet Leylek, Julian Kim, Pascal Lambert, Oliver Bucher, William Hunter, Gokulan Sivananthan, Rashmi Koul, Shrinivas Rathod
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Current Oncology
Subjects:
biomarkers
early-stage lung cancer
stereotactic body radiation therapy
Online Access:https://www.mdpi.com/1718-7729/29/1/19

Internet

https://www.mdpi.com/1718-7729/29/1/19

Similar Items